Chemoinformaics analysis of Adenostemmoic acid F
| Molecular Weight | 350.455 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 22 |
| Exact Molecular Weight | 350.209 | nRing | 6 |
| Solubility: LogS | -3.817 | nHRing | 2 |
| Solubility: LogP | 1.757 | No. of Aliphatic Rings | 6 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 57.4138 |
| nHD | 3 | BPOL | 32.7002 |
| QED | 0.676 |
| Synth | 6.468 |
| Natural Product Likeliness | 3.131 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.154 |
| Pgp-sub | 0.026 |
| HIA | 0.009 |
| CACO-2 | -5.589 |
| MDCK | 0.0000161 |
| BBB | 0.814 |
| PPB | 0.635537 |
| VDSS | 0.37 |
| FU | 0.377189 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.787 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.634 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.045 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.242 |
| CYP3a4-sub | 0.108 |
| CL | 2.079 |
| T12 | 0.704 |
| hERG | 0.043 |
| Ames | 0.049 |
| ROA | 0.872 |
| SkinSen | 0.87 |
| Carcinogencity | 0.846 |
| EI | 0.07 |
| Respiratory | 0.974 |
| NR-Aromatase | 0.748 |
| Antiviral | Yes |
| Prediction | 0.544625 |